Clinical trial
The "COSMOS"-Study (Copeptin in Osmoregulation and Stress Assessment)
NCT00390962 · University Hospital, Basel, Switzerland, Other · Completed
Key facts
| NCT number | NCT00390962 |
|---|---|
| Title | The "COSMOS"-Study (Copeptin in Osmoregulation and Stress Assessment) |
| Official title | Copeptin as a Novel Diagnostic and Prognostic Marker in the Management of Neurological and Neurosurgical Patients With Sodium Imbalance The "COSMOS"-Study (Copeptin in Osmoregulation and Stress Assessment) |
| Lead sponsor | University Hospital, Basel, Switzerland, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Stroke, Transient Ischemic Attack |
| Enrollment | 469 |
| Start date | Nov 1, 2006 |
| Primary completion | Mar 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Oct 23, 2006 |
| Last update posted | Sep 23, 2008 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: